sodium channel blockers (Astellas/Kotobuki)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namesodium channel blockers (Astellas/Kotobuki)
Drug Alias NameASP-1120ASP-9596
ClassificationSmall molecules
Mechanisms of ActionSodium channels blockers
TargetsSodium channels
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma IncKotobuki Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A